INDIA IMMUNO-ONCOLOGY DRUGS MARKET ANALYSIS
India immuno-oncology drugs market is estimated to be valued at US$ 265 Mn in 2021 and is expected to exhibit a CAGR of 13.1% during the forecast period (2021 -2028).
Figure 1. India Immuno-Oncology Drugs Market (US$ Mn), By Drug Type, 2021
Figure 1.1. India Immuno-Oncology Drugs Market (US$ Mn), By Drug Type, 2028
The increasing developments and product launches are expected to drive the market growth over the forecast period.
India Immuno-Oncology Drugs Market – Impact of Coronavirus (Covid-19) Pandemic
The coronavirus (COVID-19) pandemic is the most recent outbreak, which was first reported on December 31, 2019, in Wuhan, China. The shutdown disrupted the supply, distribution, and manufacturing of medical supplies globally. Moreover due to social distancing, footfall in clinics and health institutions was observed which has led to a decrease in the number of surgical procedures, clinical trials, research and development activities, and others, which has negatively impacted the market growth.
Market Trends: Increasing developments and product launches
For instance, researchers from Tata Centre for Technology and Design, IIT Bombay, are currently working on developing indigenous CAR T-cell therapy, affordable to cancer patients in the India.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
